Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.

导出 OA

翻译打印收藏纠错

作者： Andrés F,Henao-Martínez ^[1] ; Daniel B,Chastain ^[2] ; George R,Thompson ^[3]

作者单位： Department of Medicine, Division of Infectious Diseases, University of Colorado Aschutz Medical Campus , Aurora, Colorado, USA. ^[1] Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy , Albany, Georgia, USA. ^[2] Department of Medicine, Division of Infectious Diseases, University of California, Davis Medical Center , Sacramento, California, USA. ^[3] Department of Medical Microbiology and Immunology, University of California, Davis Medical Center , Sacramento, California, USA. ^[4]

关键词 Aspergillus aspergillosis drug therapy invasive pulmonary mortality

主题词人类(Humans);抗真菌药(Antifungal Agents);侵袭性肺曲霉菌病(Invasive Pulmonary Aspergillosis);氟康唑(Fluconazole);棘白菌素类(Echinocandins);肺曲霉菌病(Pulmonary Aspergillosis)

DOI 10.1128/aac.00721-23

PMID 37671871

发布时间 2023-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交